genome editing

A new system for simultaneous genomic edits could unlock better models of complex diseases.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

Researchers are using CRISPR for precise genetic manipulation of human-associated microbes as a promising avenue for improving human health.

An iterative engineering approach to improve prime editor delivery helped scientists correct genetic vision defects in mice.

Samantha Maragh has taken on the difficult challenge of standardizing assays, data norms, and terminology in the ever evolving genome editing field.

Two groups independently discovered that Fanzor proteins in eukaryotic organisms are CRISPR’s genome-editing cousins.

Researchers leave no stone unturned in the search for a spinal muscular atrophy treatment strategy that uses base editing.

Researchers turned to base editors to correct mutations causing the rare genetic disease Fanconi anemia without inducing double-strand DNA breaks.

Taking inspiration from her PhD research, Ana Moreno formed a company where scientists use CRISPR to treat chronic pain

The results reveal evolutionary relatives of the Cas9 enzyme now used extensively in biotechnology.

The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.

Emmanuelle Charpentier and Jennifer Doudna reprogrammed the bacterial immune response into one of the most popular tools for genetics and molecular biology.

The International Commission on the Clinical Use of Human Germline Genome Editing claims the technology is still too risky for therapeutic use.